$MDB

MongoDB (MDB) Stock Surges Past $450 as Wall Street Analysts Boost Forecasts

MongoDB (MDB) shares rose above $450, near $452.89 after a 52-week high of $447. Analysts raised forecasts, led by Oppenheimer increasing its target from $410 to $475 while keeping Outperform. Needham, Tigress Financial, and Stifel also lifted targets. The article cites Q1 Atlas growth of 29% and revenue above estimates.

Original reporting
Published Aug 13, 2026, 2:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 6:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MongoDB (MDB) Stock Surges Past $450 as Wall Street Analysts Boost Forecasts — source image
Decision brief

The 30-second read

$MDBBullishMed
01

Why it matters

The article’s actionable driver is the fresh analyst target reset (Oppenheimer $410 to $475) and corroborating target hikes from other firms, which can extend momentum. Risk is that the valuation is already above an intrinsic-value estimate and profitability remains weak.

02

Market read

MDB is trading at a 52-week high area with bullish sell-side revisions, but the text also highlights valuation risk versus intrinsic value and ongoing losses.

03

What to watch

Insider selling ($53.7M over three months) and negative TTM EPS (-$0.37) suggest the rally could be fragile if consumption growth decelerates or margins fail to trend toward breakeven.

Relevance 7/10Novelty 6/10Timing: today’s session after-hours/early trading around the $447-$452 range following Aug 12 target upgrades

Background

MongoDB’s rally is attributed here to Wall Street target increases, with Atlas growth cited as the underlying operating driver.

Company-level read

Ticker impact

$MDBBullishMedium confidence
Context

Oppenheimer upgraded MongoDB’s price target to $475 from $410 while keeping Outperform, adding fresh upside framing for MDB shares near $452.89.

Expected impact

Near-term upside bias with elevated volatility; follow-through depends on whether Atlas growth and consumption dynamics keep beating expectations.

Evidence & confidence

The newest disclosed fact is the Oppenheimer target increase (Aug 12) plus multiple other target lifts, which can drive momentum. However, the text also notes GF Value implying the stock trades above intrinsic value and TTM EPS remains negative, limiting downside protection if growth slows.

Market effects

Reinforces positive sentiment toward AI data infrastructure and database platform spend, potentially supporting peer multiples tied to Atlas-like growth narratives.

Primarily US large-cap tech/software sentiment, with institutional flows implied by the 52-week breakout.

Limited direct global linkage in the text beyond AI capex expectations.

Counterpoint

The stock appears priced above intrinsic value per GF Value, so upgrades may be partially “sell the news” if profitability does not improve.

Key entities

  • MongoDB, Inc.

    Subject of the article; shares near $452.89 after a 52-week peak touch and multiple analyst target increases.

  • Oppenheimer

    Upgraded MDB price target to $475 from $410 while maintaining Outperform (Aug 12).

  • Needham

    Set a $430 price objective, citing AI-related capital expenditures as a catalyst.

  • Tigress Financial

    Raised target to $515, emphasizing AI-driven data infrastructure positioning.

  • Stifel

    Lifted target to $435, citing Atlas platform expansion and improving consumption dynamics.

Related articles

$DTMed

Markets round-up: Dynatrace, IGEL, MongoDB

Dynatrace will acquire Arize for $915m in cash and stock, including about $815m in cash and replacement equity awards, to expand AI observability. IGEL partnered with Menlo Security for zero-trust browser access. MongoDB made Atlas available via an MCP server for tools like Claude Code. Okta said an AI agent feature can cut token costs up to 89%.

$MDBMed

Financial Times improves AI retrieval accuracy in 100,000-plus searches

MongoDB (NASDAQ: MDB) said MongoDB Atlas added “Automated Embeddings” for high-precision AI context retrieval on live operational data, powered by Voyage AI models. It also launched an Atlas Embedding and Reranking API, voyage-code-4 for code retrieval, and vector search in Atlas Stream Processing. Financial Times and Eve are cited as users; features are generally available.

$MDBMed

MongoDB Pops As Citi Flags Big Upside Ahead - TipRanks.com

MongoDB shares rose after Citi cited near-term catalysts including the next earnings report, a product cycle, and an investor day. Citi raised its MongoDB price target to $545 from $455 and kept a Buy rating, adding a 90-day upside catalyst watch. The article notes MongoDB’s cash generation and low debt, but flags slowing revenue growth and Atlas consumption dependence.

$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

$MDBMedAI 9/10

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.